Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type B/hepatitis B vaccine

Neal A Halsey, Mark Blatter, Gerald Bader, Mary Lou Thoms, Field F. Willingham, J. Crossan O'Donovan, Lawrence Pakula, Florence Berut, Keith S. Reisinger, Carlton Meschievitz

Research output: Contribution to journalArticle

Abstract

Background. Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children. Objectives. The purpose of this study was to assess the safety and immunogenicity of three schedules using IPV administered with diphtheria and tetanus toxoids and whole cell pertussis vaccines in a dual-chambered syringe. Children also received a combination of Hacmophilus influenzae type b (Hib) and hepatitis B vaccines (COMVAX(TM)). Methods. All infants (n = 295) received IPV and COMVAX(TM) at 2 and 4 months of age and IPV, oral poliovirus vaccine (OPV) or both vaccines at 6 months and OPV at 15 months of age. Results. After two doses of IPV 96 to 100% of infants had antibodies to poliomyelitis viruses types 1, 2 and 3, and after a third dose of vaccine (IPV or OPV) all but one child had antibodies to all three poliovirus types. After two doses of COMVAX(TM) 89 and 96% of children had protective levels of antibody to Hib and hepatitis B, respectively. Conclusions. IPV is highly immunogenic in a two-dose schedule. Administration of a thirddose of IPV or a dose of OPV at 6 months of age is highly effective. Simultaneous administration of a combination H. influenzae type b/hepatitis B vaccine did not interfere with the response to IPV.

Original languageEnglish (US)
Pages (from-to)675-679
Number of pages5
JournalPediatric Infectious Disease Journal
Volume16
Issue number7
DOIs
StatePublished - Jul 1997

Fingerprint

Inactivated Poliovirus Vaccine
Oral Poliovirus Vaccine
Hepatitis B Vaccines
Haemophilus influenzae
Human Influenza
Antibodies
Appointments and Schedules
Vaccines
Diphtheria Toxoid
Pertussis Vaccine
Haemophilus influenzae type b
Tetanus Toxoid
Poliovirus
Syringes
Poliomyelitis
Advisory Committees
Hepatitis B

Keywords

  • Combination vaccines
  • Inaetivated poliovirus vaccine
  • Oral poliovirus vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Cite this

Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type B/hepatitis B vaccine. / Halsey, Neal A; Blatter, Mark; Bader, Gerald; Thoms, Mary Lou; Willingham, Field F.; O'Donovan, J. Crossan; Pakula, Lawrence; Berut, Florence; Reisinger, Keith S.; Meschievitz, Carlton.

In: Pediatric Infectious Disease Journal, Vol. 16, No. 7, 07.1997, p. 675-679.

Research output: Contribution to journalArticle

Halsey, Neal A ; Blatter, Mark ; Bader, Gerald ; Thoms, Mary Lou ; Willingham, Field F. ; O'Donovan, J. Crossan ; Pakula, Lawrence ; Berut, Florence ; Reisinger, Keith S. ; Meschievitz, Carlton. / Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type B/hepatitis B vaccine. In: Pediatric Infectious Disease Journal. 1997 ; Vol. 16, No. 7. pp. 675-679.
@article{bcbf02cafc86470ca872abea99e15681,
title = "Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type B/hepatitis B vaccine",
abstract = "Background. Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children. Objectives. The purpose of this study was to assess the safety and immunogenicity of three schedules using IPV administered with diphtheria and tetanus toxoids and whole cell pertussis vaccines in a dual-chambered syringe. Children also received a combination of Hacmophilus influenzae type b (Hib) and hepatitis B vaccines (COMVAX(TM)). Methods. All infants (n = 295) received IPV and COMVAX(TM) at 2 and 4 months of age and IPV, oral poliovirus vaccine (OPV) or both vaccines at 6 months and OPV at 15 months of age. Results. After two doses of IPV 96 to 100{\%} of infants had antibodies to poliomyelitis viruses types 1, 2 and 3, and after a third dose of vaccine (IPV or OPV) all but one child had antibodies to all three poliovirus types. After two doses of COMVAX(TM) 89 and 96{\%} of children had protective levels of antibody to Hib and hepatitis B, respectively. Conclusions. IPV is highly immunogenic in a two-dose schedule. Administration of a thirddose of IPV or a dose of OPV at 6 months of age is highly effective. Simultaneous administration of a combination H. influenzae type b/hepatitis B vaccine did not interfere with the response to IPV.",
keywords = "Combination vaccines, Inaetivated poliovirus vaccine, Oral poliovirus vaccine",
author = "Halsey, {Neal A} and Mark Blatter and Gerald Bader and Thoms, {Mary Lou} and Willingham, {Field F.} and O'Donovan, {J. Crossan} and Lawrence Pakula and Florence Berut and Reisinger, {Keith S.} and Carlton Meschievitz",
year = "1997",
month = "7",
doi = "10.1097/00006454-199707000-00010",
language = "English (US)",
volume = "16",
pages = "675--679",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type B/hepatitis B vaccine

AU - Halsey, Neal A

AU - Blatter, Mark

AU - Bader, Gerald

AU - Thoms, Mary Lou

AU - Willingham, Field F.

AU - O'Donovan, J. Crossan

AU - Pakula, Lawrence

AU - Berut, Florence

AU - Reisinger, Keith S.

AU - Meschievitz, Carlton

PY - 1997/7

Y1 - 1997/7

N2 - Background. Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children. Objectives. The purpose of this study was to assess the safety and immunogenicity of three schedules using IPV administered with diphtheria and tetanus toxoids and whole cell pertussis vaccines in a dual-chambered syringe. Children also received a combination of Hacmophilus influenzae type b (Hib) and hepatitis B vaccines (COMVAX(TM)). Methods. All infants (n = 295) received IPV and COMVAX(TM) at 2 and 4 months of age and IPV, oral poliovirus vaccine (OPV) or both vaccines at 6 months and OPV at 15 months of age. Results. After two doses of IPV 96 to 100% of infants had antibodies to poliomyelitis viruses types 1, 2 and 3, and after a third dose of vaccine (IPV or OPV) all but one child had antibodies to all three poliovirus types. After two doses of COMVAX(TM) 89 and 96% of children had protective levels of antibody to Hib and hepatitis B, respectively. Conclusions. IPV is highly immunogenic in a two-dose schedule. Administration of a thirddose of IPV or a dose of OPV at 6 months of age is highly effective. Simultaneous administration of a combination H. influenzae type b/hepatitis B vaccine did not interfere with the response to IPV.

AB - Background. Advisory committees have recommended the increased use of inactivated poliovirus vaccine (IPV) for children. Objectives. The purpose of this study was to assess the safety and immunogenicity of three schedules using IPV administered with diphtheria and tetanus toxoids and whole cell pertussis vaccines in a dual-chambered syringe. Children also received a combination of Hacmophilus influenzae type b (Hib) and hepatitis B vaccines (COMVAX(TM)). Methods. All infants (n = 295) received IPV and COMVAX(TM) at 2 and 4 months of age and IPV, oral poliovirus vaccine (OPV) or both vaccines at 6 months and OPV at 15 months of age. Results. After two doses of IPV 96 to 100% of infants had antibodies to poliomyelitis viruses types 1, 2 and 3, and after a third dose of vaccine (IPV or OPV) all but one child had antibodies to all three poliovirus types. After two doses of COMVAX(TM) 89 and 96% of children had protective levels of antibody to Hib and hepatitis B, respectively. Conclusions. IPV is highly immunogenic in a two-dose schedule. Administration of a thirddose of IPV or a dose of OPV at 6 months of age is highly effective. Simultaneous administration of a combination H. influenzae type b/hepatitis B vaccine did not interfere with the response to IPV.

KW - Combination vaccines

KW - Inaetivated poliovirus vaccine

KW - Oral poliovirus vaccine

UR - http://www.scopus.com/inward/record.url?scp=17344395367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344395367&partnerID=8YFLogxK

U2 - 10.1097/00006454-199707000-00010

DO - 10.1097/00006454-199707000-00010

M3 - Article

VL - 16

SP - 675

EP - 679

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 7

ER -